Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Internal Medicine (Tokyo, Japan)|July 3, 2015
An Open-label Longitudinal Study on the Efficacy of Switching from Insulin Glargine or Detemir to Degludec in Type 2 Diabetes MellitusIppei Kanazawa, Masakazu Notsu, Ken-ichiro Tanaka, et al.
Calcified Tissue International|November 11, 2016
Bazedoxifene Ameliorates Homocysteine-Induced Apoptosis and Accumulation of Advanced Glycation End Products by Reducing Oxidative Stress in MC3T3-E1 CellsIppei Kanazawa, Tsutomu Tomita, Shun Miyazaki, et al.
Biochemical and Biophysical Research Communications|December 23, 2008
BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosisKumi Hayashi, Toru Yamaguchi, Shozo Yano, et al.
Endocrine Journal|February 5, 2016
Simvastatin rescues homocysteine-induced apoptosis of osteocytic MLO-Y4 cells by decreasing the expressions of NADPH oxidase 1 and 2Ayumu Takeno, Ippei Kanazawa, Ken-Ichiro Tanaka, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2009
Adiponectin is associated with changes in bone markers during glycemic control in type 2 diabetes mellitusIppei Kanazawa, Toru Yamaguchi, Mika Yamauchi, et al.
Bone|May 19, 2009
Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetesToru Yamaguchi, Ippei Kanazawa, Masahiro Yamamoto, et al.
Endocrine Journal|May 22, 2008
Serum DHEA-S level is associated with the presence of atherosclerosis in postmenopausal women with type 2 diabetes mellitusIppei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2007
The uraemic toxin phenylacetic acid inhibits osteoblastic proliferation and differentiation: an implication for the pathogenesis of low turnover bone in chronic renal failureShozo Yano, Toru Yamaguchi, Ippei Kanazawa, et al.
The Journal of Clinical Endocrinology and Metabolism|November 6, 2008
Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitusIppei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto, et al.
Biochemical and Biophysical Research Communications|December 30, 2015
Activation of AMP-activated protein kinase decreases receptor activator of NF-κB ligand expression and increases sclerostin expression by inhibiting the mevalonate pathway in osteocytic MLO-Y4 cellsMaki Yokomoto-Umakoshi, Ippei Kanazawa, Ayumu Takeno, et al.
Pageof 11